Spectral Computed Tomography Market Size was valued at USD 8.0 Billion in 2023. The Global Spectral Computed Tomography industry is projected to grow from USD 8.8 Billion in 2024 to USD 17.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.00% during the forecast period (2024 - 2032).
Spectral computed tomography is also known as dual-energy CT which is techniques that are used two individual x-ray photon energy spectra and allows the interrogation of materials which has different attenuation properties at different energies in another word it is basically an advanced medical imagining device which is helpful in differentiating and characterizing tissues with the help of the high quality of x-ray images.
Spectral Computed Tomography has two different energy spectra which concisely produce material density-based images of spectral computed tomography. The major factor that is responsible for the growth of the Spectral Computed Tomography (CT) market is the increasing prevalence of diseases including neurological disorders, cancer, and cardiac diseases around the world. The rising expenditure in the IT sector on healthcare and the advancement in the technology of diagnostics sectors are some other major factors for the market growth.
In September 2022, Royal Philips, a prominent player in health technology, announced additional progress in creating the world's first spectral detector angio CT solution, known as the Philips Spectral Angio CT suite*. This innovative suite combines the company's revolutionary spectral CT imaging technology with an integrated hybrid angio CT suite. Philips intends to provide doctors with instant access to both Spectral CT 7500 system and Image Guided Therapy System - Azurion with FlexArm in a single room. This integration of advanced imaging modalities and interventional suite solution will facilitate advancements in minimally-invasive procedures, particularly in the fields of oncology, stroke, and trauma care. Philips unveiled a new clinical collaborator and highlighted the importance of clinical research that centers on the added advantage of integrating spectral CT imaging technology in interventional procedures.
In June 2023, MARS Bioimaging, a company based in New Zealand, formed a partnership with the Hospital for Special Surgery (HSS) to enhance the field of musculoskeletal imaging and diagnostics. The partnership centers on MARS' photon-counting spectral CT imaging technology. The HSS Innovation Institute and MARS will work together to examine specific components of the MARS 5120 Extremity Scanner and explore the development of novel scanning techniques and technologies. The MARS 5120 Extremity scanner was developed using the MediPix3 detector technology, which was originally developed as a result of continuous particle physics research conducted at the European Laboratory for Particle Physics (CERN). In the past, MARS employed this method to develop the inaugural commercial (2010) photon-counting 3D color X-ray. It facilitated the production of high-contrast images of bone structure and the evaluation of bone density at a fracture location, all while utilizing far lower levels of radiation compared to traditional CT scans.
This report contains all the information on the Spectral Computed Tomography market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the Spectral Computed Tomography (CT) market analysis and forecast to 2025 is also included in the report.
Covid 19 Analysis
The rising cases of covid 19 across the globe have raised the demand for CT scanners which is likely to out positive impact on the Spectral Computed Tomography table. According to the reports, the Abu Dhabi Health Services Company (SEHA) has introduced a mobile CT scanner in the United Arab Emirates in order to detect pneumonia in patients of covid 19. This is proof that hospitals are taking the help of the CT scanner to detect covid 19.
Market Dynamic
The increased chronic diseases, the rising geriatric population across the globe, the advancement in the technological field, and the preferences of image-guided interventions in the medical field are the major driving factor for the growth of the spectral computed tomography (CT) market.
The rising adaptation of IT in the medical field in order to improve the product quality is a major step in the spectral computed tomography (CT) market. It is creating major opportunities in the health care sector as it plays an important role in the medical devices industries by enhancing product efficiency at every level of use. Medical image management is directly linked with diagnosis services and it is an important part of the healthcare IT sector.
The high cost involved in spectral computed tomography is likely to create a hurdle in the growth of the spectral computed tomography (CT) market. The easy availability of imaging methods in the market is projected to hamper the spectral computed tomography (CT) market growth.
The availability of alternative imaging methods in the spectral computed tomography (CT) market is projected to create major challenges for the key manufacturers in the market.
Cumulative Growth Analysis
According to the reports, the spending on the healthcare it sector has been increasing rapidly from the past few years which is predicted to boost the spectral computed tomography (CT) market and the related services as well during the forecast period of 2019 to 2025. The approval and acceptance of cloud technology in medical image devices offer easy sharing of data and storage, it also raises the acquisitions and mergers between IT companies and healthcare which ultimately accelerates the growth of the spectral computed tomography market. The adoption of cloud technology in medical imaging in the developed countries like Japan, the UK, and the US are contributing to the market growth.
Value Chain Analysis
According to the reports, the spectral computed tomography market is segmented on the basis of application, end-users, and regions. On the basis of application, the Spectral Computed Tomography (CT) market has been segmented into oncology, gastrointestinal diseases, cardiology, and musculoskeletal disorders. Oncology segments are predicted to witness the maximum Spectral Computed Tomography (CT) market share during the forecast period. On the basis of end-users, the Spectral Computed Tomography market has been segmented into diagnostic centers, and hospitals & clinics.
Segmentation Overview
The market is segmented on the basis of the application, end-users, and regions. The spectral computed tomography market is expected to witness decent growth during the forecast period.
By Application
Based on the application, the market is segmented into oncology, gastrointestinal diseases, cardiology, and musculoskeletal disorders.
By end-users
Based on the propulsion types, the market is segmented into diagnostic centers, and hospitals & clinics.
Regional Analysis
According to the reports, on the basis of regions the spectral computed tomography (CT) market has based segmented into the Americas, Europe, Asia Pacific, and Middle East & Africa. The Asia Pacific segment is predicted to hold the largest Spectral Computed Tomography market share due to the rising prevalence of cancer, carnivorous diseases, and also due to the rising geriatric population with several diseases. America is predicted to hold the second-largest spectral computed tomography (CT) market share during the forecast period due to the presence of several medical device companies, innovation in devices to enhance the quality of life, and easing expenditure on healthcare.
The European region holds the third-largest spectral computed tomography market share due to the increasing numbers of medical device industries, rise in per capita income of individuals, the more spending by consumers n healthcare, and the presence of developed countries in these regions are the major factor for the growth of the spectral computed tomography (CT) market in this region.
Competitive landscape
The prominent key players of the Spectral Computed Tomography market are focused on making strategies to increase the demand for Spectral Computed Tomography (CT). The innovation, developments in products, and mergers & acquisitions are the key strategies of these prominent players in the Spectral Computed Tomography market.
Major Key Players
Report Overview
The following report comprises of –
Recent Developments
Market Segmentation
Spectral Computed Tomography Market, by Application
Spectral Computed Tomography Market, by End User
Spectral Computed Tomography Market, by Region
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 17.2 Billion (By 2032) |
| Â Â CAGR | Â Â 8.00% |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2022 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Application and End User |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â General Electric Company (US), Koninklijke Philips N.V. (Amsterdam, Netherlands), MARS Bioimaging Ltd (Christchurch, New Zealand), Neusoft Corporation (China), Shenzhen Anke High-tech Co., Ltd (China), Siemens (UK), and PerkinElmer Inc. (Waltham, Massachusetts) |
| Â Â Key Market Opportunities | Â Â The increasing acceptance and approval of the cloud technology in medical image devices provide easy storage and sharing of huge data |
|   Key Market Drivers | · Increasing expenditure on the healthcare IT sector, and technological advancements in the diagnostics sector. · The increasing adaption of IT in medical devices to improve the quality of the product is a major step. |
Spectral Computed Tomography Market Highlights:
Frequently Asked Questions (FAQ) :
spectral CT market is expected to reach USD 17.2 Billion by 2032.
The global market is expected to exhibit a strong 8.00% CAGR over the forecast period till 2032.
The rise in demand for advanced medical imagining modalities is the major driver for the market.
Asia pacific holds the largest share in the global Spectral Computed Tomography (CT) market followed by America, Europe, and Middle East & Africa.
Leading players in the market include MARS Bioimaging, GE, and Koninklijke Philips, among others.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
